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Background: Cough is an important defensive pulmonary reflex that removes irritants, fluids or foreign materials 
from the airways. Frequently, cough is non-productive and requires suppression and opioid receptor agonists such as 
codeine are commonly used as antitussive agents. However, opioids produce side effects that include sedation, 
addiction potential and constipation. Novel cough suppressant therapies should maintain or improve upon the 
antitussive efficacy profile of opioids but with minimum or no side effects. 
Objective: To evaluate antitussive activity of combination of herbal medicines as formulations in sulphur dioxide - 
induced cough model in rats. 
Methodology: Wister rats of either sex, weighing 150 - 200 g, were divided into 7 groups (n = 6). Group 1 served as a 
control and received normal saline, groups 2 received codeine phosphate, group 3 and 4 received the coded market 
samples and groups 5, 6 and 7 received the test samples, respectively. Thirty or sixty minutes following 
administration, the rats were exposed to sulphur dioxide gas for 1 minute and then placed in an open chamber for 
counting of cough bouts. 
Results: The formulations exhibited cough inhibitions of between 15 and 27%, and 14 and 38%, with respect to the 
control group, 30 and 60 minutes after sample administration respectively. 
Conclusion: The herbal formulations demonstrated significant (p < 0.05) antitussive activity in sulphur dioxide 
induced cough model. 
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1. Introduction 
Cough is a defense mechanism that prevents the entry 
of noxious materials into the respiratory system and 
clears foreign materials and excess secretions from the 
lungs and respiratory tract (Dicpinigaitis and Gayle, 
2003). Cough is also the most common symptom of 
respiratory tract disorders and the pharmacological 
modulation of pathological cough is still unsatisfactory 
despite the existing large number of cough 
formulations. Dry coughs are treated with cough 
suppressants (antitussives), while productive coughs 
are treated with expectorants (Mason, 2002).  
Antitussives are widely available in the form of natural 
and semi-synthetic opiates such as codeine, 
ethylmorphine, dihydrocodeine and benzylmorphine 
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among others. However, these opioids alkaloids have 
inherent side effects like sedation, constipation, and 
also some addiction liability. Furthermore, their use in 
severe cough conditions like asthma is contraindicated, 
as they are known to further compromise the 
respiratory function (Braga and Allegra, 1989). 
Therefore, there is need to have effective antitussives 
which can successfully alleviate chronic cough without 
side effects. 
Many medicinal plants such as Ocimum sanctum (Nadig 
and Laxmi, 2005), Adhatoda vasica (Indian Herbal 
Pharmacopoeia, 2002; Dhule, 1999) Glycyrrhiza glabra 
(Chang and Butt, 1986), Zingiber officinale (Suekawa et 
al, 1984), Asparagus racemosus (Mandal et al, 2000), 
Passiflora incarnate (Dhawan and Sharma, 2002) and 
Ficus racemosa (Bhaskara et al, 2003) have been 
reported to have antitussive activity and it is apparent 
that the different medicinal plants work by different 
mechanisms in suppressing cough. However, there are 
very few studies available on combined activity of the 
different medicinal plants. This study evaluated safety 
and efficacy of some formulations with a combination of 
natural active plant components in sulphur dioxide 
induced cough in rat model. 
2. Materials and Methods 
2.1 The herbal cough formulation samples 
Honikof syrup, Herbigor Honey and Lemon syrup and 
Honikof tablets herbal formulations were obtained from 
the manufacturer, Universal Corporation Limited (UCL), 
Kenya. The codeine Phosphate reference standard 
(purity 99.9%) and two market samples (coded sample 
H and sample V) were also supplied by UCL. The 
composition of the test formulations and the coded 
samples are shown in Table 1. 
2.2 Animals 
Six months old male and female adult Sprague Dawley 
rats weighing 150 - 200 g subjected to natural lighting 
conditions (12 hrs of day/ 12 hrs of night) and housed 
in the animal facility at the Department of Veterinary 
Physiology, University of Nairobi, Chiromo Campus, 
were used for the antitussive evaluation experiments. 
The animals were put in groups of 5 in plastic bottomed 
cages with wire tops (45 × 28 × 21 cm) bedded with 
wood chips and fed on chow (rat feed, UNGA feeds 
Limited) and water ad libitum. The wood chip dressings 
in the cages were changed every 3 days. Before the start 
of the experiments the animals were observed for 14 
days in an isolated section of the animal house. 
Six to eight weeks old healthy Swiss albino male and 
female mice weighing 20 ± 2 g random-bred and housed 
within the KEMRI animal facility were used for the in 
vivo safety studies. The mice were moved into the 
experimental room for acclimatization one week before 
the onset of experiments. Six Swiss albino mice were 
put in standard polypropylene 15 × 21 × 29 cm 
transparent plastic cages bedded with a wood chips and 
equipped with continuous-flow nipple watering devices. 
The cages were clearly labelled with experimental 
details and the mice were fed on pellets (Mice pellets, 
UNGA feeds Limited) and water ad libitum. The wood 
chip dressings in the cages were changed every two 
days. All dying animals in the course of experiments 
were placed in well-labelled biohazard bags and sent 
for incineration. After each experiment, surviving 
animals were euthanized in carbon dioxide (CO2) 
chamber and placed in biohazard disposable bags and 
sent for incineration.  
2.3 Sample preparation 
The animal doses for both the test and market syrups 
samples were extrapolated from the human dosages as 
per the National Institutes of Health (NIH) protocol 
(Guidance August, 2007). This was done based on 
maximum adult dose as given in label claim. The 
average weight of 20 tablets was taken, powdered and 
some powder weighed out accurately and dissolved in 
10% Tween 80 in double distilled water to give a final 
concentration of 223 mg/ml for safety studies.  
Table 1: Composition of the different herbal formulations 
Honikof syrups  
(in mg/5 mL) 
Honikof tablets   
(in mg/tablet) 
Herbigor Honey & Lemon Syrup 
(per 5 mL) 
Ocimum sanctum 30 
Glycyrrhiza glabra 40 
Adhatoda vasica 40 
Zingiber officinale 5 
Piper longum 10 
Curcuma longa 2.5  
Piper nigrum 2 
Pudina satva  5 
Honey 1750 
Ocimum sanctum 15 
Glycyrrhiza glabra 15 
Adhatoda vasica 15 
Zingiber officinale 5 
Piper longum 1.5 
Curcuma longa 1.5 
Piper nigrum 1.5 
Pudina satva  10 
Lemon juice 0.9 ml 
Purified Honey 290 mg 
Liquid glucose 4gm 
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For the antitussive activity, accurately weighed 
powdered drug was dissolved in normal saline to give a 
final concentration of 361 mg/ml. For syrup; it was 15 
ml (or 20 g based on weight per ml) per 60 kg body 
weight (bw); that is 330 mg/kg body weight 
administered in a single dose. Similarly, for tablets, the 
maximum human adult dose per day is 6 tablets and the 
average weight per tablet was 1.78 g. Hence, 1.78 g x 6 
tablets per day translates to 10.68 g per 60 kg adult 
body weight (i.e. 178 mg/kg, body weight). 
2.4 Sulphur dioxide (SO2) induced cough 
Cough was induced in rats by exposure to sulphur 
dioxide gas as per the experiment model shown in 
Figure 1. Sulphur dioxide gas was generated by 
introducing concentrated sulphuric acid in B into a 
sodium hydrogen sulphite solution in A, according to 
the following reaction, according to the following 
reaction:  
2NaHSO3 + H2SO4 → 2SO2 + Na2SO4 + 2H2O.  
The generated SO2 gas was then introduced into the gas 
reservoir by opening cock b, the pressure in C was 
recorded using a water manometer D while the stop-
cock b and e are closed and the stop-cock c opened 
slightly till pressure in D reached 75 mm H2O. The rat 
was placed on the platform in the dessicator and 
exposed to SO2 for 60 sec. The rat was then removed 
from the dessicator and placed in an observation 
chamber for counting of bouts of cough for 5 min 
thereafter. In the same fashion the frequency of cough 
was measured for all the rats in the treated groups. 
Cough bouts were counted by 2 independent observers 
using digital counters (DK-100 Electronic hand counter, 
Japan) and stopwatches.  
A: flask containing aqueous sodium hydrogen sulphite solution 
B: burette filled with concentrated sulphuric acid 
C: gas storage chamber  
D: water manometer 
E: desiccator 
Figure 1: Experiment model used to generate sulphur 
dioxide gas for induction of cough in rats (Miyagoshi et 
al, 1986) 
2.5 Antitussive evaluation 
Evaluation of the antitussive activity was carried out 
based on the method of Miyagoshi et al (1986). Both 
female and male Sprague Dawley rats weighing 
between 150 and 200 g were randomly selected and 
divided into 7 groups of 6 animals each (3 males and 3 
females). The animals had free access to a standard 
animal feed and water. One served as a control group 
and received only normal saline (2 ml/kg, p.o). Two 
groups were administered with the market samples (H 
and V, 2 ml/kg, p.o), another three groups were given 
the test samples (Honikof and Herbigor Honey & Lemon 
syrups 2 ml/kg, p.o and Honikof tablets at 722 mg/kg 
bw, p.o) and the remaining group was given the 
standard antitussive drug codeine phosphate (250 
mg/kg, bw p.o).  
The animal was first given either the normal saline, test 
samples, market samples or the reference drug by 
gavage at time 0 (zero) min then  30 min after 
administration, the animal was then put into chamber E 
for one minute, taken out and the frequency of coughs 
was observed for 5 minutes in an open chamber. In the 
same way the frequency of coughs were observed for all 
the animal groups at 0 min (before drug administration) 
and at 30 and 60 min interval following drug 
administration. Fresh animals were used for the 30 and 
60 min experiments. 
2.6 In vivo safety studies 
Toxicity studies of the herbal formulations were 
performed with Swiss albino mice weighing 20 ± 2 g. 
Healthy male and female mice were randomly selected 
and put in groups of 6 animals (3 males and 3 females) 
in each cage. The animals had free access to a standard 
pellet diet and tap water ad labium, except for a 12 hr 
fasting period before oral administration of the drug. 
Both test and market sample syrups were administered 
by gavage at 0.4 ml/20 gm bw /mouse (26.6 gm/kg bw) 
in two equal divided doses at an interval of 2 hr for the 
test samples (Waako et al, 2005) and a single dose of 
2.235 gm/kg bw (44.6 mg in 0.2 ml) for the reference. 
Tween 80 was administered as the negative control. 
The general behaviour of mice was observed 
continuously for 1hr after the treatment and then 
intermittently for 4 hr, and thereafter over a period of 
48 hr for any deaths. The mice were further observed 
for up to 14 days following treatment for any signs of 
toxicity and the latency of death (Twaij et al, 1983). 
2.7 Data analysis 
The pharmacological effect was monitored as the 
number of coughs over a period of 5 minutes.  The  
experimental  results  are  expressed  as  the mean  ± the  
standard  error  of mean  (S.E.M) and the percentage 
inhibition in number of cough bouts calculated. 
Statistical Package for Social Scientists (SPSS) – 
computer statistics software version 19.0 was used for 
analysis. The baseline data was compared with number 
of coughs obtained in the presence of test formulation 
and codeine made using ANOVA. The statistical 
significance was evaluated by using the Student’s t-test. 
P-values less than 0.05 imply significance. 
2.8 Ethical issues 
The study was approved by the KEMRI Scientific 
Steering Committee (SSC) and Ethics Review Committee 
(ERC) (Proposal SSC No. 1686). The study animals 
were handled in conformity with guidelines for the 
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handling of laboratory animals of World Health 
Organization (WHO) and of KEMRI animal care and use 
committee (ACUC). 
3. Results  
Antitussive evaluation test  
The effect of the various test formulations on sulphur 
dioxide-induced cough in experimental animals is 
shown in Figure 2.  Codeine phosphate, a prototype 
antitussive agent, produced 64.63 and 82.44% 
inhibition of cough 30 and 60 min after administration, 
respectively.  The cough inhibition for Herbigor Honey 
& Lemon was 24.63 and 30.38 % while that of sample V 
syrup, a similar product in the market, was 24.39 and 
14.35 %, 30 and 60 minutes after drug administration, 
respectively.  Thirty and 60 min after treatment, the 
cough inhibition were 15.28 and 37.40 % respectively, 
for Honikof tablets. The cough inhibition for Honikof 
syrup was 17.24 and 30.38 % while that of sample H 
syrup, a product in the market with similar herbal 
ingredients, was 26.02 and 23.36%, 30 and 60 min after 
treatment, respectively. 
Figure 2: Effects  of formulations  and  codeine  phosphate  on  the  cough  induced  by  sulphur dioxide  gas  in rats 
(30 and 60 min after sample administration) 
Figure 3: Average weight of mice before treatment and 14-days after treatment 
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In vivo safety test:  
Figure 3 shows the animal weight variations before and 
14 days after test samples administration. All the 
animals registered weight gain however; those that 
received sample V syrup recorded the lowest weight 
gain of an average of 4.1 g. On general observation it 
was noted that the control group behaved normal while 
the animals were sedated in codeine group but in the 
test groups (mice treated with formulations) the mice 
were as active as the control group. There was no 
apparent sedation. No animal mortalities were 
observed in all the groups. 
4. Discussion  
The successful health-care system in most developing 
countries has been due to the support provided by 
traditional medicine and the World Health Organization 
estimates that up to 80 per cent of the world’s 
population relies mainly on herbal medicine for primary 
health care (WHO, 2002). Furthermore, around one in 
four of all prescription drugs dispensed by western 
pharmacists are likely to contain ingredients derived 
from plants. Some well-known medicines such as 
Reserpine from the root of Rauwolfia serpentina, used 
for lowering blood pressure and as a tranquilliser; L-
Dopa from a tropical legume Mucuna deeringiana, used 
for treating Parkinson’s disease; Ephedrine, a 
decongestant, from the Chinese shrub Ephedra sinica 
and Picrotoxin from Anamirta cocculus, used as a 
nervous system stimulant and in cases of barbiturate 
poisoning, have been derived from plants (BGCI Fact 
Sheet, 2000). 
Sulphur dioxide induced cough is widely used as a 
model for evaluating antitussive activity for test 
samples (Bhaskara et al, 2003; Kakali et al, 1997). In 
this study, the reference standard, codeine, treated 
animals predictably had a significantly reduced number 
of cough bouts compared to the test formulation. The 
cough inhibition was generally higher for Herbigor 
Honey & lemon syrup both at 30 min (24.63%) and 60 
min (30.38%) after drug administration in comparison 
to sample V which is currently in clinical use. However, 
the market sample showed a higher cough inhibition at 
30 min (24.39%) than at 60 min (14.35%) after drug 
administration.  The opposite effects observed with 
Herbigor Honey & lemon syrup is an indication of a 
slower on set of pharmacological activity though more 
efficacious compared to the market sample (sample V). 
Both formulations are honey based and studies have 
also shown that honey is an effective treatment for 
cough in children aged 2-18 yrs than 
dextromethorphan, an opiate-derived antitussive 
commonly found in over-the-counter cough and cold 
preparations (Paul et al, 2007; Warren et al, 2007). 
Furthermore, World Health Organization encourages 
the use of safe antitussives such as lemon juice and 
honey for the treatment of cough if treatment is desired 
by the patient and family (WHO, 2001). 
Honikof syrup exhibited high cough inhibition at 60 
minutes (30.4%) just like the Honikof tablets (37.4%) 
an indication of slow on set of pharmacological effects. 
However, the market sample currently in clinical use 
(Sample H) exhibited slightly higher activity at 30 
minutes (26.02%) than at 60 min (23.4%). Both 
Honikof tablets and syrup exhibited higher activity at 
60 min than sample H syrup. This results show that 
both formulation have better delayed therapeutic 
effects than the market product. Honey which is part of 
the ingredients in both Honitus and Honikof has been 
found to have topical demulcent effects that contribute 
to its benefits in management of cough. Herbal cough 
products are a better option given the relatively low 
adverse effect profile and potential benefit.  
Many medicinal plants have been claimed to have 
antitussive activity and have also been screened for this 
purpose, singly. Medicinal plants such as Ocimum 
sanctum, ginger, Glycyrrhiza glabra (licorice), which are 
constituents in the Honikof syrup, sample H syrup and 
probably in Honikof tablets, and others are major 
components of household cough and cold remedies 
worldwide. Some isolated experimental and clinical 
studies have also been carried out on these agents for 
cough (Nadig and Laxmi 2005; Chang and Butt, 1986; 
Suekawa et al, 1984). It is evident that the different 
medicinal plants would work by different mechanisms 
in suppressing cough and combined activity of the 
different medicinal plants are promising antitussive 
products. It was also noted that all the herbal 
formulations were devoid of sedative effects unlike the 
reference drug and this absence of sedation allows the 
patient to get on with normal working day without 
drowsiness. 
5. Conclusion  
It can be concluded that the antitussive products 
exerted signiﬁcant (p < 0.05) antitussive effect in 
experimentally induced cough reﬂex in rats comparable 
to the standard drug codeine phosphate and this 
provides pharmacological evidence in support of these 
herbal products as antitussive agents. Hence, additional 
work relating to evaluation of their mechanism of action 
for antitussive effect should be carried out. 
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